Login

Financial Snapshot

Revenue
TTM
$48.35K
Gross Margin
TTM
64.17%
Net Income
TTM
-$1.358M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
5.1%
Total Assets
2026 Q1
Total Liabilities
Last 4 Quarters
N/A
Book Value
Last 4 Quarters
N/A
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $3.59 Million

About Vystar Corp

Vystar Corp (OTC: VYST) is a materials technology company that holds patents on Vytex, a deproteinized natural rubber latex in which allergy-causing proteins are reduced to levels at or below detection based on ASTM-approved test methods. The company licenses and commercializes Vytex as a raw material to manufacturers, relying on its exclusive global distribution and market development agreement with Corrie MacColl Limited, a subsidiary of Halcyon Agri, signed in December 2020. Vytex has been available commercially for fourteen years as of the 10-K filed April 15, 2026, with end-product applications including electrical gloves, condoms, and adhesives. Vystar also holds patents on the Hughes Reactor fluid energy technology, acquired in May 2019, intended to improve its RxAir air purification product line. As of December 31, 2025, the company had cash of $4,454, a working capital deficit of $6,614,169, an accumulated deficit of $61,384,883, and a net loss of $1,531,850 for fiscal year 2025. The filing discloses substantial doubt about the company's ability to continue as a going concern.

Revenue model
Vystar's revenue model is not fully detailed in the filing excerpts, but the company commercializes Vytex natural rubber latex as a raw material through its exclusive distribution partner Corrie MacColl. The company does not currently generate cash sufficient to cover operating costs, as disclosed in the FY2025 10-K filed April 15, 2026.
Products and services
Vytex: multi-patented deproteinized natural rubber latex raw material used in electrical gloves, condoms, and adhesives, among other end products. RxAir: air purification system intended to destroy airborne pathogens. Hughes Reactor: patented fluid energy technology acquired from Fluid Energy Conversion Inc. in May 2019, intended to enhance RxAir units.
Customers and end markets
Manufacturers of rubber end products including electrical gloves, condoms, and adhesives. Research collaborations with the Indian Rubber Manufacturers Research Association targeting applications in green tires, biodegradable materials, and bioelastoplast product lines. Automotive sector outreach, including a presentation to the Automotive Tyre Manufacturers' Association in August 2021.
Value-chain role
Upstream raw material supplier and IP licensor in the natural rubber latex supply chain. Corrie MacColl Limited serves as exclusive global partner for production, market development, and distribution of Vytex.
Geographic exposure
The filing references global distribution through Corrie MacColl and research collaboration with IRMRA in India. The company is incorporated in Georgia and headquartered in the United States.

Source: SEC 10-K, filed 2026-04-15

Industry: Fabricated Rubber Products, NEC Peers: ADM Tronics Unlimited Inc Crown Electrokinetics Corp. Dow Inc Greystone Logistics Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support